Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through two segments: Proteomics and Genomics. It provides SomaScan platform that enables researchers to measure thousands of proteins simultaneously, providing deep insights into biological processes and disease mechanism; CyTOF technology platform that uses metal-tagged antibodies and time-of-flight mass spectrometry to eliminate signal interference and expand multiplexing capabilities; Hyperion, a spatial biology platform unlocks deeper insights into tissue organization by preserving spatial context while enabling high-dimensional molecular and proteomic analysis; and Biomark X9 system redefines high-throughput genomics by delivering exceptional efficiency, precision, and scalability for qPCR applications. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.

Standard BioTools Inc.

Shares of Astera Labs (ALAB) and Bloom Energy ($BE) rose about 11% and 7% on Friday. The move comes as traders bet both companies could be added to...

Astera Labs (ALAB) and Bloom Energy (BE) Soar as Investors Bet on S&P 500 Index (SPX) Inclusion

PMGC Holdings ( ($ELAB) ) just unveiled an announcement. On August 27, 2026, NorthStrive Biosciences, a wholly owned subsidiary of PMGC Holdings, e...

PMGC Holdings advances AI-driven cardiometabolic expansion program

Insiders have been trading these 5 stocks: (($ACN)), (($TSE:HIVE)), (($TEAM)), (($ALAB)) and (($TMO)). Here is a breakdown of their recent trades a...

Accenture, HIVE, Atlassian, Astera Labs & Thermo Fisher Shock

Northland Securities analyst Gus Richard upgraded Astera Labs ($ALAB) stock to Buy from Hold with a $350 price target. The five-star analyst expect...

“One of the Fastest-Growing AI Chip Plays”: Five-Star Northland Analyst Upgrades Astera Labs (ALAB) to Buy at $350

Wells Fargo analyst Brandon Couillard maintained a Hold rating on Mesa Laboratories today and set a price target of $110.00. Couillard covers the H...

Mesa Laboratories (MLAB) Receives a Hold from Wells Fargo

MediPharm Labs ( ($TSE:LABS) ) has issued an update. MediPharm Labs has scheduled the release of its second-quarter 2026 financial results for Augu...

MediPharm Labs Sets Date for Q2 2026 Results Amid Global Medical Cannabis Expansion

In a report released yesterday, from CICC maintained a Buy rating on Zai Lab Ltd, with a price target of HK$20.20. The word on The Street in genera...

CICC Keeps Their Buy Rating on Zai Lab Ltd (1ZLB)

Citi analyst maintained a Buy rating on Zai Lab Ltd on August 6 and set a price target of HK$35.10. The company’s shares closed last Thursday at HK...

Citi Sticks to Their Buy Rating for Zai Lab Ltd (1ZLB)

In a report released yesterday, from UBS maintained a Buy rating on Zai Lab Ltd, with a price target of HK$27.00. Currently, the analyst consensus ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	LAB	$0.69	+1.72%	1.76M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	LAB	$0.69	+1.7%	1.76M
3
4
5
6

LAB

Get Standard BioTools Inc. Data in Excel

Get Standard BioTools Inc. Data in Excel